ANN C STUART
Allopathic & Osteopathic Physicians|Family Medicine KNOXVILLE, TN NPI 1699873554
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine TN ABBVIE INC. All categories
General Payments — all program years on this page
$9,472.10
- Category: General Payments
- Program years: PY2018–2023
- Record count: 636
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $773.98 across 44 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $773.98 | 44 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $107.65 | 6 |
| PFIZER INC. | $100.48 | 4 |
| Acerta Pharma LLC | $80.65 | 5 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $60.53 | 4 |
| Lilly USA, LLC | $49.14 | 3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $44.82 | 3 |
| E.R. Squibb & Sons, L.L.C. | $37.45 | 2 |
| GlaxoSmithKline, LLC. | $37.41 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $33.13 | 2 |
| Amarin Pharma Inc. | $32.81 | 2 |
| Novo Nordisk AS | $30.87 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $29.02 | 1 |
| Antares Pharma, Inc. | $28.88 | 2 |
| Astellas Pharma US Inc | $26.52 | 1 |
| Halozyme Inc | $16.67 | 1 |
| Azurity Pharmaceuticals, Inc. | $16.60 | 1 |
| Merck Sharp & Dohme Corporation | $14.62 | 1 |
| SANOFI-AVENTIS U.S. LLC | $13.95 | 1 |
| Amgen Inc. | $12.78 | 1 |
By program year
Records — PY2023 (44)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.